RBC keeps USD 113.00 target for CVS Health stock at 25.01 percent upside

Published on 10/15/2026 at 15:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue was USD 106.10 billion in 2026. CVS Health stock costs EUR 81.26 on October 15, 2026, 0.64 percent above the Xetra close.

Analyst views and reporting dates

RBC Capital maintained a USD 113.00 target on October 7, 2026.
Second-quarter revenue reached USD 106.10 billion, up 7.30 percent year over year.
CVS Health stock costs EUR 81.26 at Lang & Schwarz on October 15, 2026 at 2:59 p.m. CEST, 0.64 percent above the Xetra close of October 14, 2026.
The next quarterly earnings date is November 4, 2026.

Extreme Nahaufnahme bunter pharmazeutischer Kapseln und Tabletten mit Bokeh-Hintergrund — CVS Health Corp. Makroaufnahme zeigt bunte Pharmakapseln und Tabletten in Detailansicht, ISIN US1266501006, Illustration mit AI erstellt.

RBC Capital maintained a Buy rating and set a USD 113.00 price target for CVS Health on October 7, 2026, putting the target 25.01 percent above the USD 90.39 home-market price on October 14, 2026, according to The Globe and Mail. At 2:59 p.m. CEST on October 15, 2026, CVS Health stock was trading at EUR 81.26 at Lang & Schwarz, 0.64 percent above the Xetra close of October 14, 2026.

Second-quarter revenue sets scale

For the quarter ended June 30, 2026, revenue reached USD 106.10 billion, up 7.30 percent from the same quarter a year earlier. MarketBeat reported adjusted earnings per share of USD 2.58 against a USD 1.87 consensus estimate for the same quarter. The comparison shows why the analyst target remains materially above the recent home-market quotation.

Price position and trading frame

The Lang & Schwarz bid was EUR 81.06 and the ask was EUR 81.46 at 2:59 p.m. CEST on October 15, 2026. The primary-market quote had closed at USD 90.39 on October 14, 2026. The USD 69.51 to USD 110.68 52-week range places that quote 18.33 percent below the high and 30.04 percent above the low. Trading volume was 9,331,444 shares on October 14, 2026, versus an average of 8,084,496 shares.

Valuation and November date

CVS Health had a market capitalization of USD 115.6 billion, a price-to-earnings ratio of 23.91 and a dividend yield of 3.00 percent as of October 15, 2026. The next quarterly earnings date is November 4, 2026, according to StockAnalysis.

Comparison with peers

CVS Health Corp. (NYSE, USD): plus 0.64 percent, P/E 23.91, market capitalization USD 115.6 billion, October 15, 2026.

Cigna Corporation (NYSE, USD): plus 2.50 percent, P/E 11.99, market capitalization USD 76.5 billion, October 14, 2026.

Elevance Health Inc. (NYSE, USD): plus 0.66 percent, P/E 19.03, market capitalization USD 92.8 billion, October 14, 2026.

Price and next session

The euro quote stood at EUR 81.26 at Lang & Schwarz on October 15, 2026 at 2:59 p.m. CEST, with the Xetra comparison established in the opening price sentence. The next scheduled earnings event is November 4, 2026. The further course of trading is shown by the continuously updated real-time quote of CVS Health Corp. stock.